Cargando…

Increased production of soluble CTLA-4 in patients with spondylarthropathies correlates with disease activity

INTRODUCTION: Spondylarthropathies (SpA) are characterized by abnormal immune responses including T cell activation. Cytotoxic T lymphocyte associated molecule-4 (CTLA-4) is involved in down-regulating immune responses. A soluble form of CTLA-4 (sCTLA-4), resulting from an alternative splicing, has...

Descripción completa

Detalles Bibliográficos
Autores principales:	Toussirot, Éric, Saas, Philippe, Deschamps, Marina, Pouthier, Fabienne, Perrot, Lucille, Perruche, Sylvain, Chabod, Jacqueline, Tiberghien, Pierre, Wendling, Daniel
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2745776/ https://www.ncbi.nlm.nih.gov/pubmed/19570209 http://dx.doi.org/10.1186/ar2747

Ejemplares similares

Harnessing Apoptotic Cell Clearance to Treat Autoimmune Arthritis
por: Saas, Philippe, et al.
Publicado: (2017)

Mini-Review: The Administration of Apoptotic Cells for Treating Rheumatoid Arthritis: Current Knowledge and Clinical Perspectives
por: Toussirot, Eric, et al.
Publicado: (2021)

Apoptotic cell infusion treats ongoing collagen-induced arthritis, even in the presence of methotrexate, and is synergic with anti-TNF therapy
por: Bonnefoy, Francis, et al.
Publicado: (2016)

Collagenous Colitis and Spondylarthropathy
por: Ben Abdelghani, Kaouther, et al.
Publicado: (2012)

Apoptotic cell-mediated suppression of streptococcal cell wall-induced arthritis is associated with alteration of macrophage function and local regulatory T-cell increase: a potential cell-based therapy?
por: Perruche, Sylvain, et al.
Publicado: (2009)

Increased frequency of T cells specific for EBV gp110 in the synovial fluid of patients with rheumatoid arthritis
por: Toussirot, E, et al.
Publicado: (2003)

Recent insights into the implications of metabolism in plasmacytoid dendritic cell innate functions: Potential ways to control these functions
por: Saas, Philippe, et al.
Publicado: (2017)

Resolution therapy: Harnessing efferocytic macrophages to trigger the resolution of inflammation
por: Saas, Philippe, et al.
Publicado: (2022)

Serum Adipokines and Adipose Tissue Distribution in Rheumatoid Arthritis and Ankylosing Spondylitis. A Comparative Study
por: Toussirot, Éric, et al.
Publicado: (2013)

MAIT cells: potent major cellular players in the IL-17 pathway of spondyloarthritis?
por: Toussirot, Eric, et al.
Publicado: (2018)

The Interleukin-6 Gene Promoter Polymorphism -174 and Atherosclerotic Events in Overweight Transplanted Patients
por: Bamoulid, Jamal, et al.
Publicado: (2011)

OPG and RANKL in serum and synovial fluids of patients with rheumatoid arthritis, osteoarthritis and spondylarthropathy
por: Krystufkova, O, et al.
Publicado: (2003)

Tumor necrosis factor inhibitors are associated with reduced complement activation in spondylarthropathies: An observational study
por: Hokstad, Ingrid, et al.
Publicado: (2019)

Chronic, eventually fatal, Kawasaki-like disease in an adult with spondylarthropathy responding to IVIG therapy
por: Soltner, Elise, et al.
Publicado: (2009)

Effects of Antirheumatic Treatment on Cell Cholesterol Efflux and Loading Capacity of Serum Lipoproteins in Spondylarthropathies
por: Hokstad, Ingrid, et al.
Publicado: (2022)

Editorial: Recent Advances in Potential Biomarkers for Rheumatic Diseases and in Cell-Based Therapies in the Management of Inflammatory Rheumatic Diseases
por: Saas, Philippe, et al.
Publicado: (2022)

Increased IL-22- and IL-17A-Producing Mucosal-Associated Invariant T Cells in the Peripheral Blood of Patients With Ankylosing Spondylitis
por: Toussirot, Éric, et al.
Publicado: (2018)

Could Sodium Chloride be an Environmental Trigger for Immune-Mediated Diseases? An Overview of the Experimental and Clinical Evidence
por: Toussirot, Eric, et al.
Publicado: (2018)

Low bone mineral density is related to male gender and decreased functional capacity in early spondylarthropathies
por: van der Weijden, M. A. C., et al.
Publicado: (2010)

Immune cell transcript modules reveal leukocyte heterogeneity in synovial biopsies of seronegative spondylarthropathy patients
por: Hallett, Robin M, et al.
Publicado: (2014)

Linking genotype to cell function in chronic inflammation: analysis of the IL-23/Th17 axis in spondylarthropathy
por: Roumier, M, et al.
Publicado: (2010)

Pro-Resolving Factor Administration Limits Cancer Progression by Enhancing Immune Response Against Cancer Cells
por: Wetzel, Audrey, et al.
Publicado: (2022)

The shared epitope revisited: shared epitope negative HLA-DR alleles influence susceptibility to rheumatoid arthritis
por: Reviron, D, et al.
Publicado: (2001)

Convalescent plasma to treat COVID-19: Following the Argentinian lead
por: Tiberghien, Pierre, et al.
Publicado: (2021)

Effect of methotrexate and anti-TNF on Epstein-Barr virus T-cell response and viral load in patients with rheumatoid arthritis or spondylarthropathies
por: Miceli-Richard, Corinne, et al.
Publicado: (2009)

Early Post-Transplant Red Blood Cell Transfusion Is Associated With an Increased Risk of Transplant Failure: A Nationwide French Study
por: Gaiffe, Emilie, et al.
Publicado: (2022)

Investigation of Soluble and Transmembrane CTLA-4 Isoforms in Serum and Microvesicles
por: Esposito, Laura, et al.
Publicado: (2014)

Factors Produced by Macrophages Eliminating Apoptotic Cells Demonstrate Pro-Resolutive Properties and Terminate Ongoing Inflammation
por: Bonnefoy, Francis, et al.
Publicado: (2018)

Pro-Resolving Factors Released by Macrophages After Efferocytosis Promote Mucosal Wound Healing in Inflammatory Bowel Disease
por: Martin-Rodriguez, Omayra, et al.
Publicado: (2021)

Elevated Adiponectin Serum Levels in Women with Systemic Autoimmune Diseases
por: Toussirot, Éric, et al.
Publicado: (2010)

Management of ankylosing spondylitis with infliximab
por: Toussirot, Éric, et al.
Publicado: (2009)

The soluble CTLA-4 receptor and its role in autoimmune diseases: an update
por: Saverino, Daniele, et al.
Publicado: (2010)

Lack of correlation between the levels of soluble cytotoxic T-lymphocyte associated antigen-4 (CTLA-4) and the CT-60 genotypes
por: Purohit, Sharad, et al.
Publicado: (2005)

TGFβ2 Induces the Soluble Isoform of CTLA-4 – Implications for CTLA-4 Based Checkpoint Inhibitor Antibodies in Malignant Melanoma
por: Khanolkar, Rahul C., et al.
Publicado: (2022)

L-66 Le plasma convalescent COVID-19 pour le traitement de la COVID-19
por: Tiberghien, Pierre, et al.
Publicado: (2022)

The Role of CTLA-4 Exon-1 49 A/G Polymorphism and Soluble CTLA-4 Protein Level in Egyptian Patients with Behçet's Disease
por: Abdel Galil, Sahar M., et al.
Publicado: (2014)

A Soluble Form of CTLA-4 Is Present in Paediatric Patients with Acute Lymphoblastic Leukaemia and Correlates with CD1d(+) Expression
por: Simone, Rita, et al.
Publicado: (2012)

Immunoregulatory soluble CTLA-4 modifies effector T-cell responses in systemic lupus erythematosus
por: Dahal, Lekh N., et al.
Publicado: (2016)

Antibody-mediated neutralization of soluble MIC significantly enhances CTLA4 blockade therapy
por: Zhang, Jingyu, et al.
Publicado: (2017)

Gene and protein expression of a soluble form of CTLA-4 in a healthy dog
por: TAGAWA, Michihito, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_3qbk86sn75d1vm3jptot652up2